High Throughput Drug Sensitivity and Genomics Data in Developing Individualized Treatment in Patients With Relapsed or Refractory Multiple Myeloma or Plasma Cell Leukemia
Clinical trial NCT03389347 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03389347
- Sponsor
- University of Washington
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2018-02-14
- Primary completion
- 2024-12-19
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.